Dexcel Pharma Technologies Ltd.
Sector: Pharma - Therapeutics
Medical Field: General Health
Technological Field: Pharmaceuticals and Drug Delivery Platforms
Year Established: 1965
Dexcel Pharma is a privately owned pharmaceutical company engaged in discovery, development, manufacturing and commercialization of innovative pharmaceutical products based on sophisticated proprietary controlled release oral solid dosage form drug delivery technologies. Dexcel is presently active in 18 countries, employs 621 people worldwide and maintains operations in Israel, the United Kingdom, Germany and the U.S. The company markets over 80 products in more than 200 dosages, principally in solid oral dosage form. Dexcel's products treat conditions in the largest therapeutic markets, including Cardiovascular (CVS), Gastroenterology (GE), Central Nervous System (CNS) and Dental Health Care.